fda approved glp 1 agonists How Employers Can Optimize Benefits in the Era of GLP-1s PDB-101: Molecule of the Month:
Description
GLP-1 protein expression was also detected in intestinal mucosal tissue

Kosiborod MN, Deanfield J, Pratley R, et al

The cells in your gut or intestine secrete it to regulate blood sugar levels

Am J Respir Cell Mol Biol (2016) 55:80414

Verma S, Poulter NR, Bhatt DL et al (2018) Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke
[119] conducted a phase II clinical trial in patients with NASH, that is, a placebo-controlled trial of subcutaneous sommarutide in the treatment of NASH, and found that sommarutide treatment resulted in a significantly higher proportion of patients in remission of NASH compared with placebo
